A tetracycline-responsive Myh6 promoter was fused to a cDNA encoding human BNIP3. Immunoreactivity following activation of this transgene is increased 50-fold without changing the relative abundance of major cardiac anti-apoptotic Bcl2 family proteins. (J:127533)